About the Conference

“Cancer and Cardiovascular Disease," the third conference in a three-part U13 Bench-to-Bedside series sponsored by the National Institute on Aging, the American Geriatrics Society and, the American College of Cardiology is scheduled for October 18-19, 2021 in Washington, D.C. A preliminary agenda for the conference can be accessed HERE
Heart disease and cancer remain the two leading causes of death among older Americans, but medical advancements have transformed them into chronic conditions. Recent attention has focused on the clinical interface between these two conditions. Age-related changes in inflammatory response, stem cell regeneration, or metabolism and insulin regulation may be implicated in the pathogenesis of both conditions. Emerging data suggest chemo-therapy cardiotoxicity involves disrupted cell signaling and cellular senescence. Prognostication and treatment decisions for each condition are impacted by the presence of the other condition.

The conference will include a professional development track for young investigators who are rising stars in their fields to ensure continued excellence in tomorrow’s generation of geriatrics researchers. The expected outcome is sustainable bridges between significant knowledge silos, all with strong relevance to geriatric care.
The conference is being developed by a committee of recognized experts of different clinical specialties, research disciplines and levels of seniority with expertise and/or interests in multimorbidity and major age-related conditions. The format of the conference will allow for networking, discussion and small group work to foster a “think tank” environment to stimulate new ideas, delineate new opportunities, and forge sustainable collaborations. Following the conference, a summary of the conference findings and recommendations on future research will be published in the Journal of the American Geriatrics Society.
You will need to complete the following application to attend. Applications must be completed by Monday, June 14, 2021. The application will be reviewed by the Conference Planning Committee and applicants will be informed by the end of July 2021.

Please note, we are planning an in-person conference, but we will follow CDC guidance and local policies at the time of the conference. We will consider special requests for other ways accepted attendees can participate (virtually) on a case-by-case basis, although we encourage applicants to plan to attend in-person, if allowed and possible.